Avricore Health (AVCRF) Cost of Revenue (2009 - 2025)

Avricore Health has disclosed Cost of Revenue across 15 years of filings, most recently posting $65600.6 for Q3 2025.

• In Q3 2025, Cost of Revenue fell 88.23% year-over-year to $65600.6; the TTM figure through Sep 2025 stood at $739546.2 (down 65.63% YoY), while the FY2025 annual figure was $211559.4, down 90.03% from the prior year.
• Cost of Revenue improved to $65600.6 in Q3 2025, from $55418.1 in the prior quarter.
• Over the last five years, Cost of Revenue for AVCRF reached as high as $626512.5 in Q4 2023 and fell as low as $4683.7 in Q1 2021.
• The 5-year median for Cost of Revenue is $165369.4 (2023), against an average of $247702.9.
• Annual changes were most pronounced in 2022 — Cost of Revenue jumped 2801.41% — and 2025, when it sank 88.76%.
• A 5-year view of Cost of Revenue shows it stood at $20526.0 in 2021, then jumped by 2801.41% to $595543.3 in 2022, then gained by 5.2% to $626512.5 in 2023, then slipped by 11.04% to $557363.2 in 2024, then plunged by 88.23% to $65600.6 in 2025.
• According to Business Quant data, Cost of Revenue over the past three periods registered $65600.6, $55418.1, and $61164.2 for Q3 2025, Q2 2025, and Q1 2025 respectively.